Dermatitis News

Adults with eczema may be at a higher risk for developing cardiovascular diseases, according to recent study results in The Journal of Allergy and Clinical Immunology.

FDA approvals of treatments for rosacea lesions and acne scars were the most read articles during the past week in Healio Dermatology. 

Moderate-to-severe atopic dermatitis was found to have a potential association with central obesity and increased blood pressure in children and adolescents, according to recently published study results.

Data from a study published in the Journal of Allergy and Clinical Immunology demonstrate dupilumab was associated with a dose-dependent improvement in atopic dermatitis transcriptome compared with placebo.

Pruritus appears to be a common and frequently overlooked symptom of small-fiber neuropathies, according to a study.

Velocity Pharmaceutical Development and Tigercat Pharma have announced positive phase 2 study results for use of the investigational oral NK-1 receptor antagonist, VPD-737, for treating patients with severe chronic pruritus who did not respond to standard care.

Eczema in childhood or adulthood generally was not associated with short stature; however, a small percentage of children between the ages of 10 and 11 with eczema and insufficient sleep experienced a negative effect on growth, according to study results.

The U.S. Food and Drug Administration has issued a safety announcement warning that the antipsychotic drug ziprasidone is associated with a potentially fatal skin reaction known as Drug Reaction with Eosinophilia and Systemic Symptoms.

Patients with vitiligo, especially early-onset disease, or alopecia areata had a significantly increased risk for atopic dermatitis, according to recently published study results.

Helicobacter pylori positivity was associated with physician-diagnosed asthma in children up to age 6 years, but had an inverse association with ever wheezing and eczema in children of non-Western ethnicity, according to data presented at UEG Week.